Please use this identifier to cite or link to this item:
http://repositorio.ufla.br/jspui/handle/1/45766| metadata.artigo.dc.title: | COVID-19 vaccine and boosted immunity: nothing ad interim to do? |
| metadata.artigo.dc.creator: | Roncati, Luca Vadalà, Maria Corazzari, Veronica Palmieri, Beniamino |
| metadata.artigo.dc.subject: | COVID-19 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Corynebacterium parvum (C. parvum) Bacillus Calmette-Guérin (BCG) Hyaluronic acid Cluster of differentiation 44 (CD44) Vaccine |
| metadata.artigo.dc.publisher: | Elsevier |
| metadata.artigo.dc.date.issued: | Nov-2020 |
| metadata.artigo.dc.identifier.citation: | RONCATI, L. et al. COVID-19 vaccine and boosted immunity: nothing ad interim to do? Vaccine, [S.l.], v. 38, n. 48, p. 7581-7584, Nov. 2020. |
| metadata.artigo.dc.description.abstract: | Today, Coronavirus Disease 2019 (COVID-19) is a global public health emergency and vaccination measures to counter its diffusion are deemed necessary. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the etiological agent of the disease, unleashes a T-helper 2 immune response in those patients requiring intensive care. Here, we illustrate the immunological mechanism to train the immune system towards a more effective and less symptomatic T-helper 1 immune response, to be exploited against SARS-CoV-2. |
| metadata.artigo.dc.identifier.uri: | https://www.sciencedirect.com/science/article/pii/S0264410X20313037 http://repositorio.ufla.br/jspui/handle/1/45766 |
| metadata.artigo.dc.language: | en_US |
| Appears in Collections: | FCS - Artigos sobre Coronavirus Disease 2019 (COVID-19) |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.